BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 11, 2025
Breaking News: 100 days of uncertainty
See today's BioWorld Science
Home
» CRL4 inhibition as a possible approach for treating ovarian cancer
To read the full story,
subscribe
or
sign in
.
Cancer
CRL4 inhibition as a possible approach for treating ovarian cancer
Jan. 29, 2025
Researchers from the U.S. have discovered a new therapeutic target for the treatment of ovarian cancer.
BioWorld Science
Cancer
